Page last updated: 2024-08-23

epirubicin and Chromosomal Instability

epirubicin has been researched along with Chromosomal Instability in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartlett, JM; Boutros, PC; Burnell, M; Chen, BE; D'Costa, A; Levine, MN; Lyttle, N; O'Brien, P; Shepherd, L; Spears, M; Yao, CQ	1

Trials

1 trial(s) available for epirubicin and Chromosomal Instability

Article	Year
A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial. Oncotarget, 2016, Aug-02, Volume: 7, Issue:31 Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Chromosomal Instability; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gene Expression Profiling; Humans; Middle Aged; Paclitaxel; Prognosis; Taxoids	2016

Article

Year

A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial.

Oncotarget, 2016, Aug-02, Volume: 7, Issue:31

Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Chromosomal Instability; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gene Expression Profiling; Humans; Middle Aged; Paclitaxel; Prognosis; Taxoids

2016